LONG TERM REMISSION/SURVIVAL OVER 8 YEARS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ICT-107 DENDRITIC CELL-BASED IMMUNOTHERAPY (PHASE I)

S. Phuphanich,C. Wheeler,J. Rudnick,J. Hu,M. Mazer,M. Nuno,C. Sanchez,R. Chu,K. Black,J. Yu

NEURO-ONCOLOGY（2016）

引用 1|浏览19

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要